A trial of doramectin injection and ivermectin spot-on for treatment of rabbits artificially infested with the ear mite Psoroptes cuniculi

Similar documents
Study of Control Against Mange Mite (Sarcoptes scabiei) in Naturally Infested Rabbits in Sohag Governorate, Egypt

Ear canker and its Clinical Management in Rabbits

Octodectes cynotis in cats and dogs diagnosis and management techniques

PHENOTYPING BELGIAN BLUE CATTLE FOR THEIR SUSCEPTIBILITY TO PSOROPTIC MANGE

Field efficacy and prophylaxis of extra label 0.5 % moxidectin pour on in a flock of sheep naturally infested with sarcoptes scabiei

Saunders Solutions in Veterinary Practice Small Animal Dermatology by Anita Patel and Peter Forsythe 2008 Elsevier Ltd. All rights reserved.

International Journal of Science, Environment and Technology, Vol. 5, No 6, 2016,

Sheep Scab. Fig. 1: Sheep scab can be introduced from stray sheep - this perimeter fence is not secure.

Clinical Article DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF DEMODICID OTODECTIC MALASSEZIAL OTITIS EXTERNA IN A POODLE PUP

Summary of Product Characteristics

COMMON MANGE IN DOGS AND CATS days spent on the dog Females burrow tunnels in the stratum corneum to lay eggs

SUMMARY OF PRODUCT CHARACTERISTICS

UPDATE ON THE DIAGNOSIS AND MANAGEMENT OF DEMODICOSIS

THERAPEUTIC MANAGEMENT OF SARCOPTIC MANGE IN RABBIT WITH IVERMECTIN

Doug Carithers 1 William Russell Everett 2 Sheila Gross 3 Jordan Crawford 1

Summary of Product Characteristics

ANNEX I. Marketing Authorisation Holder (Name and address): Reference Member State:

Pesky Ectoparasites. Insecta fleas, lice and flies. Acari- ticks and mites

Efficacy of Moxidectin 6-Month Injectable and Milbemycin Oxime/Lufenuron Tablets Against Naturally Acquired Toxocara canis Infections in Dogs*

Eprimec. The PROVEN endectocide that increases your profits.

Therapeutic efficacy of a mixture of ivermectin and closantel against gastrointestinal parasites in draft horses

Cydectin. Fort Dodge PRODUCT DESCRIPTION

MOXIDECTIN SPOT-ON SOLUTION FOR KITTENS AND SMALL CATS. 280 mg/ml FLURALANER 14 mg/ml MOXIDECTIN Also contains: 339 mg/ml DIMETHYLACETAMIDE (solvent)

The Surveillance programme for Psoroptes ovis in llama (Lama glama) and alpaca (Vicugna pacos) in Norway in 2017

Summary of Product Characteristics

SUMMARY OF THE PRODUCT CHARACTERISTICS

SUMMARY OF THE PRODUCT CHARACTERISTICS

Sarcoptic Mange in Pigs A review. Lee McCosker. 28 th August Introduction

FREEDOM OF INFORMATION SUMMARY

FEEDLOT PERFORMANCE, HEALTH, AND CARCASS CHARACTERISTICS OF BEEF HEIFERS TREATED WITH CYDECTIN OR DECTOMAX AT PROCESSING

A Field Study on Efficacy of Albendazole (Albezol ) Against Gastro-intestinal Nematodes in Ruminants

Deworming: Relationships, Resistance, Refugia

Cydectin Pour-On for Cattle

Doug Carithers 1 Jordan Crawford 1 William Russell Everett 2 Sheila Gross 3

For the treatment and prevention of infections caused by:

US Federal law restricts this drug to use by or on the order of a licensed veterinarian.

discover the nextgeneration of flea & tick protection NEW TASTY CHEW ONE CHEW ONCE A MONTH

A Parasiticide for the Treatment and Control of Internal and External Parasites of Cattle and Swine

Effects of an Ivermectin Otic Suspension on Egg Hatching of the Cat Ear Mite, Otodectes cynotis, in Vitro*

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre

SUMMARY OF PRODUCT CHARACTERISTICS

Kathryn Rook, VMD DACVD Clinical Assistant Professor of Dermatology University of Pennsylvania, School of Veterinary Medicine.

Meningeal worm (deer, brain worm) Parelaphostrongylus tenuis by Dr. Mary Smith DVM & Dr. tatiana Stanton

Incredible. xng237353_techdetailer4thtick9x12_rsg.indd 1

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

THE VETERINARIAN'S CHOICE. Compendium clinical Trials. Introducing new MILPRO. from Virbac. Go pro. Go MILPRO..

Mites. Glossary/Terminology

DOSE TITRATION, EFFICACY AND SAFETY OF DROP ON IVERMECTIN FOR THE MANAGEMENT OF KNEMIDOCOPTES SPP INFESTATION IN BUDGERIGARS.

The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF

SUMMARY OF PRODUCT CHARACTERISTICS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Cattle Ectoparasites and Their Control Rachel Mallet, Bimeda Professional Services Vet

Nadja Rohdich *, Rainer KA Roepke and Eva Zschiesche

Canine Care Guide To Demodectic Mange READ ONLINE

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Comparative efficacy of DRAXXIN or Nuflor for the treatment of undifferentiated bovine respiratory disease in feeder cattle

Mosquitoes & Diseases. Maxwell Lea, Jr. DVM State Veterinarian Louisiana Dept. of Agriculture and Forestry Department of Animal Health Services

Veterinary Parasitology 112 (2003)

In 2013 The FDA Approved The Use Of Advantage Multi For The Prevention Of Heartworms And Fleas On Us Ferrets Too!

We Check Your Pets For Internal Parasites

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Sarcoptes scabiei, the itch mite causes a stubborn

Comparative Evaluation of the Speed of Flea Kill of Imidacloprid and Selamectin on Dogs*

Demodex in Puppies. Demodectic mange looks like hair loss in small dime to quarter shapes on the face and forelegs.

Control of Chorioptic Mange Mites on Horses, Donkeys, and Mules

Moredun Research Institute

Science and Art of Flea and Tick Control:

Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats

PROTECT HERD PERFORMANCE

The Reconsideration of Approvals and Registrations Relating to FIPRONIL

SUMMARY OF PRODUCT CHARACTERISTICS

Spot-on for Dogs and Cats

VETERINARSKI ARHIV 81 (6), , arhiv 81, , ABSTRACT

Unshakeable confidence

Fluralaner (mg) for small cats kg for medium-sized cats > kg for large cats > kg 1.

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

Rx, For use by or on the order of a licensed veterinarian.

Summary of Product Characteristics

Summary of Product Characteristics

Demodectic mange (unlike sarcoptic mange) is not considered a very contagious disease and isolation of affected dogs is not considered necessary.

In cattle: For the treatment of infections with the following parasites

Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site:

Comparison of Efficacy, Side Effects, and Cost of Isoxasolines and Ivermectin Against Generalized Canine Demodicosis

VETERINARY MEDICINAL PRODUCTS CONTROLLING VARROA JACOBSONI AND ACARAPIS WOODI PARASITOSIS IN BEES

SUMMARY OF PRODUCT CHARACTERISTICS. Equimax Tabs Vet, 150 mg / 20 mg, Chewable tablet for Horses

Summary of Product Characteristics

LOVE DESERVES LASTING ITCH REL EF. CYTOPOINT has been shown to be effective for the treatment of dogs against allergic and atopic dermatitis.

LOVE DESERVES LASTING ITCH REL EF. CYTOPOINT has been shown to be effective for the treatment of dogs against allergic and atopic dermatitis.

SUMMARY OF PRODUCT CHARACTERISTICS

Biosecurity in sheep flocks

Eprinex Multi 5 mg/ml pour-on for beef and dairy cattle, sheep and goats. Active substance: Eprinomectin mg

Efficacies of fenbendazole and albendazole in the treatment of commercial turkeys artificially infected with Ascaridia dissimilis

Course Curriculum for Master Degree in Poultry Diseases/Veterinary Medicine

External Parasites on Swine 1

Indian Journal of Canine Practice Volume 6 Issue 2, December, 2014

Comparative Curative Efficacy of Two Spot On Formulations, Fipronil/Amitraz/ (S)-Methoprene and Imidacloprid/ Permethrin, on Two Tick Species in Dogs

Order Strongylida. Superfamilies: Trichostrongyloidea Strongyloidea Metastrongyloidea Ancylostomatoidea (hookworms)

NEW CLAIM: Simparica: Key Benefits. (sarolaner) chewable tablets ROCK-SOLID FLEA AND TICK PROTECTION FOR DOGS. The only oral product licensed to treat

SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

Polish Journal of Veterinary Sciences Vol. 20, No. 3 (2017), 521 525 DOI 10.1515/pjvs-2017-0063 A trial of doramectin injection and ivermectin spot-on for treatment of rabbits artificially infested with the ear mite Psoroptes cuniculi Original article N.M. Elhawary 1, SH. S.G.H. Sorour 1, M.A. El-Abasy 3, E.K. Bazh 2, K. Sultan 1 1 Department of Parasitology, Faculty of Veterinary Medicine, Kafrelsheikh University, 33516 Kafrelsheikh, Egypt 2 Department of Pathology and Parasitology, Faculty of Veterinary Medicine, Damanhour University, 22111 Damanhour, Egypt 3 Department of Poultry Diseases, Faculty of Veterinary Medicine, Kafrelsheikh University, 33516 Kafrelsheikh, Egypt Abstract The ear mite Psoroptes cuniculi is the main cause of ear mange, a highly contagious parasitic skin disease in rabbits all over the world. In the current work, a preliminary therapeutic trial to study the effect of the broad use acaricides doramectin and ivermectin on P. cuniculi was performed on artificially infested rabbits. Twenty five adult New Zealand white rabbits were used in this study. The rabbits were assigned randomly into five groups/ 5 rabbits in each group. Each rabbit was experimentally infested with 100 mites/ ear. The first group was designated the positive control group and was not treated. The second and third groups were treated with doramectin 200 and 400 μg/kg bw, respectively. Groups 4 and 5 were treated by dressing with ivermectin in one dose and 2 doses with a 1 week interval. After the therapy, all rabbits were examined microscopically on the 7 th,14 th, and 28 th day post treatment and the number of live mites (larvae, nymphs, and adults) on each rabbit was counted at the end of the experiment (28 th day). The results showed that the rabbits treated subcutaneously with doramectin at a single dose of 200 μg /kg bw showed a very low effect, although there was significant improvement when the dose was doubled to 400 μg /kg bw, with the number of mites counted decreasing significantly. Rabbits treated topically with ivermectin spot-on, a single dose or 2 doses, showed great improvement of the lesion: the number of mites was reduced to zero. In conclusion, this work showed that ivermectin spot-on applied locally on infested ears proves to be more effective against P. cuniculi than doramectin injected subcutaneously. Further trials on ear mange therapeutics in rabbits are to be encouraged. Key words: rabbits, Psoroptes cuniculi, ear mange, treatment, ivermectin, doramectin Correspondence to: K. Sultan, e-mail: khaled.soultan1@vet.kfs.edu.eg

522 N.M. Elhawary et al. Introduction Ear mange caused by Psoroptes cuniculi is a common parasitic disease worldwide in domestic rabbits (White et al. 2002). Psoroptes mites are cosmopolitan ectoparasites that infest several mammalian hosts; the ear mite, P. cuniculi, is a highly contagious mite which mainly affects the rabbit and usually lives inside the ear pinnae, where it reproduces in a quick life cycle (Burke 1992, Harkness and Wagner 1997). P. cuniculi infestation also causes reduction of body weight and may result in death, as it feeds on serous exudate, skin secretions and blood, causing pruritis in untreated rabbits, with the formation of crusts and scabs (Bates 1999, Beck 2000, Wall and Shearer 2001). In addition, P. cuniculi can spread to other parts of the body of the host, causing a generalized pruritis and crusting dermatitis of the head and neck (Hughes 2004), ventral abdomen and urogenital regions (Wall and Shearer 2001). Furthermore, it is zoonotic parasite as it can easily infest human beings (Burke 1992, Harrenstien et al. 1995, Acaret al. 2007). The choice of an effective acaricidal drug is an important question for all veterinarians as well as rabbits holders, to combat the serious problem of mite infestation. The cost, efficacy, toxicity and application method of the acaricidal drug should be taken into account in selecting treatment for ear mange in rabbits. Multiple drugs and therapeutics can be used in treatment of ear mange such as ivermectin (Bowman et al. 1992, Kurade et al. 1996), doramectin (Narayanan et al. 2004, Kanbur et al. 2008), selamectin (McTier et al. 2003, Kurtdede et al. 2007, Farmaki et al. 2009) and moxidectin (Wagner and Wendlberger 2000); all these drugs in various doses and several routes of delivery have been reported to be effective against P. cuniculi in rabbits. The aim of the present study was to carry out a preliminary trial to assess the therapeutic effect on P. cuniculi infestation of two commonly used acaricidal agents (doramectin and ivermectin), in order to find a safe, convenient and easily applicable treatment to control this highly contagious parasitic skin disease. Materials and Methods Collection and quantification of the adult mite of P. cuniculi Live P. cuniculi mites were collected from naturally infested rabbits in the Kafrelsheikh Governorate, Egypt. Infestation was identified by macroscopic lesions and confirmed through microscopic examination, selecting and counting P. cuniculi with a mobility and morphology coincident with those described in earlier studies (Lekimme et al. 2006, Bowman 2009). Experimental design and treatment strategy Twenty five adult New Zealand white rabbits of the same age were used in these experiments. The rabbits were kept under farm conditions, at room temperature (15-25 o C). All rabbits were healthy and fed on balanced rations and had a clean source of water ad libitum. Ethical approval The sampling procedures adhered to institutional ethical and animal care guidelines, and all methods were conducted in accordance with the Guide for the Care and Use of Laboratory Animals. Experiment procedures After one week of purchasing and housing of rabbits, experimental infestation was carried out by placing previously collected live mites in the ear conduct (100 mites/ear), which was occluded with cotton held with tape (Siegfriedet al. 2004, Calleros et al. 2013). To confirm that the rabbits were infested with the mites, microscopic examination of ear swabs of the external ear canal mixed with mineral oil from each rabbit was carried out. During the course of the experiment, all rabbits were observed carefully and weighed daily. Rabbits were assigned randomly into five groups (5 rabbits each). Each rabbit in all groups was experimentally infested. Rabbits in the first group underwent the same procedure, excluding application of treatment. This group (G1) was the positive control group. The second and third groups (G2 & G3) were treated with doramectin (Dectomax, Pfizer, Egypt) 200 μg/kg bw and 400 μg/kg bw delivered by subcutaneous injection, respectively. Finally, groups G4 & G5 were treated by dressing with ivermectin (Iverzine lotion 1%, Unipharma, Egypt) delivered topically by spot-on in one dose and 2 doses with a 1 week, respectively. After 3 weeks of experimental infestation, the tested drugs were applied as mentioned above (i.e. 0 day post treatment). After therapy, all rabbits were examined microscopically on the 7 th,14 th, and 28 th day post treatment. To calculate the efficacy of the experiment,

A trial of doramectin injection... 523 Fig 1. Ear of artificially infested rabbit with Psoroptes cuniculi showing formation of crusts and scabs. the number of live mites (larvae, nymphs, and adults) on each rabbit was counted at the end of the experiment (i.e. 28th day post treatment). Statistical analysis Statistical analysis was performed using SPS software (SPS, 2007) to assess the presence of statistically significant differences in the therapeutic effects of the treatments used. We corrected for significance values using Duncan s multiple range test (Gomez and Gomez 1984). Statistical significance was set at p<0.01. The efficacy of the treatment with doramectin injection and ivermectin spot-on was calculated using the formula below: Efficacy % = Mean of MPG from GC Mean of MPG from GT 100 Mean of MPG from GC Where: MPG: Mites per gram of crust, GC: control group, and GT: treated group. The efficacies were categorized as: highly effective when Efficacy % > 98%; effective when 90-98%; moderately effective 80-89%; and insufficiently effective < 80% (Ordination 79/1996 MERCOSUL, GMC, 1996: In Holsback et al. 2016). Results After the infestation of P. cuniculi mites was established successfully, clinicopathological features of ear mange infestation were observed in all infested groups (G1 to G5). These features were restlessness, severe inflammation and irritation of the ear pinna, and accumulation of a yellowish brown, sour smelling discharge leading to crust and ulcer formation (Fig. 1). Severe itching and head shaking to get rid of the discharge was evidenced and documented. In cases of severe mite infestation, torticollis, oblique position and the turning in a circular direction of the afflicted rabbit was apparent, due to the mites penetrating the inner ear and the base of the brain. This was manifested most clearly in the infested but untreated control positive group (G1). Artificial infestation was confirmed microscopically by demonstration of P. cuniculi in ear swabs from infected groups. There was little amelioration of the mites in rabbits treated with doramectin at a single dose of 200 μg/kg bw/ by subcutaneous injection (G2). This appeared from the number of living mites. However, doramectin administered at a dose of 400 μg/kg bw (G3) significantly reduced the number of mites, which became scare (Table1). No mortality occurred and there were no adverse effects in performance or in body weight in both groups treated with doramectin. Finally, rabbits treated topically with locally applied ivermectin lotion (Iverzine1%) in a single application (G4) or 2 applications with 1 week interval (G5) exhibited a marked decrease in the number of mites, which were reduced to zero in group G5 (Table 1). No mortality or adverse effects occurred, either in rabbits performance or in their body weight, in the groups that were treated with ivermectin.

524 N.M. Elhawary et al. Table 1. Efficacy comparison of dormectin injection and ivermectin spot-on to treat Psoroptes cuniculi, efficacy calculated based on number of living mites per gram / ear scraping in control and treated rabbit groups. Rabbit Group G1 G2 G3 G4 G5 R1 100 22 0 2 0 R2 67 30 0 0 0 R3 60 55 4 0 0 R4 90 5 0 0 0 R5 80 45 7 0 0 Mean** 79.4 a 31.4 b 2 cd 0.4 d 0 d Efficacy (%) 60.45 97.48 99.50 100.00 D = dead; R = Rabbit; ** = p<0.01 Means designated by the same letter are not significantly different at 5% level using Duncan s multiple range test. * G1 = infected and non-treated control, G2 = infected and treated by doramectin subcutaneous injection at a dose 200 μg/kg bwt, G3 = infected and treated by doramectin subcutaneous injection at a dose 400 μg/kg bwt, G4 = infected and treated by ivermectin local dressing once, and G5 = infected and treated by ivermectin local dressing twice at 1 week interval. Discussion The ear mite P. cuniculi is a universal ectoparasite frequently found on rabbits. Lesions are usually restricted to the ears, but without proper medication and control, these ectoparasites may spread vigorously (Saunders, 1979). In the persent study, a preliminary experiment was performed to investigate the effect of doramectin (s/c injection) and ivermectin (topical dressing) on P. cuniculi in experimentally infested rabbits. The avermectins are a group of potent, broad spectrum antiparasitic drugs that act as an agonist of the GABA (gamma aminobutyric acid) neurotransmitter in nerve cells. Avermectins also bind to glutamate-gated chloride channels in the nerve and muscle cells of invertebrates. In both cases, the drug blocks the transmission of neuronal signals of the parasites and causes paralysis and death of the parasites(chabalaetal.1980,albers-schoenbergetal. 1981). Doramectin is a highly effective acaricidal drug when applied subcutaneously, in a dose of 200 μg/kg bw for treatment of P. cuniculi infestation (Narayanan et al. 2004, Voyvoda et al. 2005, Kanbur et al. 2008) and also when applied in a dose of 400 μg/kg bw (Kaya et al. 2010). In our experiment, doramectinwasusedin2dosesof200μg/kg body weight and 400 μg/kg bw as recommended. The findings showed that using 200 μg/kg bw for the treatment of P. cuniculi infestation is not effective for the complete elimination of mites. The findings show that using 400 μg/kg bw is more effective than using the lower dose (200 μg/kg bw). This was apparent from the number of mites eliminated, as shown in Table 1. No adverse effect was observed in doramectin-treated groups during the whole course of the experiment. It is concluded that using doramectin in a dose of 400 μg/kg bw is the recommended dose for treatment of P. cuniculi infestation in rabbits. The topical application of acaricidal drugs like ivermectin and salamectin in order to treat P. cuniculi infested rabbits is an effective and convenient method (McTier et al. 2003, Kurtdedeet al. 2007, Fisheret al. 2007, El-Abasyet al. 2008). The results of the present study confirm that a single topical application of ivermectin 1% spot-on can completely eliminate mites from rabbits infested with P. cuniculi (i.e.g4). Our results show that no live ear mites were recovered from any ivermectin spot-on treated rabbits in group G5, while all control rabbits (G1) remained infested with P. cuniculi mites. This result agrees with the results of (El-Abasyet al. 2008, Kaya et al. 2010). Moreover, the topical application of ivermectin did not negatively affect the rabbits performance or body condition, nor did it cause any mortality in the treated rabbits. It is found to be easier and safer to deliver the drug by local application, like ivermectin, than by subcutaneous injection, like doramectin. Inconclusion:thisstudywasapreliminarytrial to treat rabbits experimentally infested with P. cuniculi by two drugs of different methods of application; doramectin by subcutaneous injection and ivermectin by local topical application. Further experiments and investigations on acaricidal therapeutics against rabbit mange are highly encouraged to test its efficacy and side effects.

A trial of doramectin injection... 525 Acknowledgments The authors wish to express their deep gratitude to all members of the Parasitology Department, Faculty of Veterinary Medicine, Kafrelsheikh University for their valuable help in this study. Also, they are thankful to Agatha Bardoel for her language revision of the manuscript. References Acar A, Kurtdede A, Ural K, Cingi CC, Karakurum MC, Yaci BB, Sari B (2007) AnEctopicCaseofPsoroptes cuniculi InfestationinaPetRabbit.TurkJVetAnim Sci 31: 423-425. Albers-Schoenberg G, Arison BH, Chabala JC, Douglas AW, Eskola P, Fisher MH (1981) Avermectins:Structure determination. J Am Chem Soc 103: 4216-4221. Bates PG (1999) Inter and intra-specific variation within the genus Psoroptes (Acari: Psoroptidae). Vet Parasitol 83: 201-217. Beck W (2000) Ear mange in domestic rabbit caused by Psoroptes cuniculi (Acari: Psoroptidae) Biology of Psoroptes cuniculi, pathogenesis, clinical features, diagnosis and treatment. Kleintierprax 45: 301-308. Bowman DD (2009) Georgis Parasitology for Veterinarians 9th ed. Saunders-Elsevier Publishers, Missouri, pp 64-70. Bowman DD, Fogelson ML, Carbone LG (1992) Effectof ivermectin on the control of ear mites (Psoroptes cuniculi) in naturally infested rabbits. Am J Vet Res 53: 105-109. Burke TJ (1992) Skin disorders of rodents, rabbits and ferrets. In: Kirk RW, Bonagura JD (eds) Current Veterinary Therapy XI Small Animal Practice. W.B. Saunders Co., Philadelphia, London, Toronto, pp 1170-1175. CallerosCH,MontorJM,MontielJA,HoffmanKL,Rodrtguez AN, Perez FI (2013) Hormonal and behavioral changes induced by acute and chronic experimental infestation with Psoroptes cuniculi in the domestic rabbit Oryctolagus cuniculus. Paras Vectors 6: 361. Chabala JC, Mrozik H, Tolman RL, Eskola P, Lusi A, Peterson LH (1980) Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem 23: 1134-1136. El-AbasyMA,DesoukyAY,AbdienHM(2008) Comparative field efficacy of systemic, oral and topical application of ivermectin against Psoroptes cuniculi, the ear mangemiteinnaturallyinfectedrabbits.kafrelsheikh Vet Med J 6: 460-470. Farmaki R, Koutinas AF, Papazahariadou MG, Kasabalis D, Day MJ (2009) Effectiveness of a selamectin spot-on formulation in rabbits with Sarcoptic mange. Vet Rec 164: 431-432. Fisher M, Beck W, Hutchinson MJ (2007) Efficacy and Safety of Selamectin (Stronghold /Revolution TM )Used Off-Label in Exotic Pets. Int J Appl Res Vet Med 5: 87-96. Gomez KA, Gomez A.A. (1984) Statistical Procedures for Agricultural Research. 2 nd ed., Jahn Wiley Sons, New York, pp 217-215. Harkness JE, Wagner JE (1977) The Biology and Medicine of Rabbits and Rodents. Lea & Febiger Publication, Philadelphia, pp 73-75. Harrenstien L, Gentz EJ, Carpenter JW (1995) How to handle respiratory, ophthalmic, neurologic, and dermatologic problems in rabbits. Symposium on Rabbit Medicine. Vet Med: 373-380. Holsback L, Luppi PAR, Silva CS, Negrão GK,CondeG, Gabriel HV, Balestrieri JV, Tomazella L (2016) Anthelmintic efficiency of doramectin, fenbendazole, and nitroxynil, in combination or individually, in sheep worm control. Rev Bras Parasitol Vet 25: 353-358. Hughes JE (2004) Diagnosis and treatment of selected rabbit dermatologic disorders. Exot DVM 5: 18-20. Kanbur M, Atalay O, Ica A, Eraslan G, Cam Y (2008) The curative and antioxidative efficiency of doramectin and doramectin+vitamin AD3E treatment on Psoroptes cuniculi infestation in rabbits. Res Vet Sci 85: 291-293. Kaya D, Inceboz T, Kolatan E, Guneli E, Yilmaz O (2010) Comparison of efficacy of ivermectin and doramectin against mange mite (Sarcoptes scabiei) innaturallyinfested rabbits in Turkey. Vet Itali 46: 51-56 KuradeNP,BhatTKandJithendranKP(1996) Effectof ivermectin against ear mange mite (Psoroptes cuniculi) in naturally infested rabbits. World Rabbit Sci 4: 25-27. Kurtdede A, Karaer Z, Acar A, Guzel M, Cingi CC, Ural K, Ica A (2007) Use of selamectin for the treatment of Psoroptic and Sarcoptic miteinfestationinrabbits.vet Dermatol 18: 18-22. LekimmeM,MignonB,TombeuxS,FocantC,MarechalF, Losson B (2006) In vitro entomopathogenic activity of Beauveria bassiana against Psoroptes spp. (Acari: Psoroptidae). Vet Parasitol 139: 196-202. McTier TL, Hair A, Walstrom DJ, Thompson L (2003) Efficacy and safety of topical administration of selamectin for treatment of ear mite infestation in rabbits. J Am Vet Med Assoc 223: 322-324. Narayanan K, Rajendiran AS, Rajapandi S (2004) Effectof doramectin on the treatment of ear and skin mange in rabbits. Ind Vet J 81: 628-630. Saunders EB (1979) Ear-mite infestation. Vet Med Small Anim Clin 74: 218-219. SiegfriedE,OchsH,DeplazesP(2004) Clinical development and serological antibody responses in sheep and rabbits experimentally infested with Psoroptes ovis and Psoroptes cuniculi. Vet Parasitol 124: 109-124. Voyvoda H, Ulutas B, Eren H, Karagenc T, Bayramli G(2005) Use of doramectin for treatment of Sarcoptic mange in five Angora rabbits. Vet Dermatol 16: 285-288. Wagner R, Wendlberger U (2000) Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes species, Demodex species and Psoroptes species mites. Vet Parasitol 93: 149-158. Wall R, Shearer D (2001) The diagnosis and control of ectoparasitic infestation. In: Veterinary Ectoparasites- -Biology, Pathology & Control. 2nd ed., Oxford, London, Edinburgh: Blackwell, 179-242. White SD, Bordeau PJ, Meredith A (2002) Dermatologic problems of rabbits. Semin Avian Exot Pet Med 11: 141-150.